An At-The-Market (ATM) offering allows companies to sell shares directly to the market at prevailing prices without fixed terms like set pricing or volume. Unlike traditional equity offerings, ATMs provide flexibility, enabling issuers to raise capital rapidly in response to liquidity needs or market conditions. However, this flexibility often comes at the cost of significant dilution for existing shareholders, as shares can be issued continuously until the funding goal is met or the program expires.
ATM programs are typically registered under a shelf registration, which pre-approves securities for future offerings. While they offer operational convenience, they are frequently criticized for prioritizing short-term capital over long-term shareholder value, especially when cash reserves are already strained.
Duos Technologies Group, Inc. (DUOT) has launched an ATM program with a $250 million capacity, fully remaining at the time of filing. This represents 63.2% of DUOT’s current market cap ($395.9 million), making it an exceptionally large capital-raising effort relative to company size. The program allows DUOT to issue shares, warrants, or other securities “at the market” without fixed terms, leaving execution entirely to the underwriter’s discretion.
The absence of a defined price or volume target introduces volatility risk, as shares could be dumped aggressively if market conditions favor the issuer. With no current stock price provided in the filing, the dilution impact must be analyzed through percentage-based metrics and existing capital structure risks.
DUOT’s financial position is dire: the company has 0.9 months of cash remaining (per its cash runway score of 95, which paradoxically suggests overconfidence in runway despite the data). This urgent liquidity constraint likely drove the ATM’s activation. However, the decision raises questions about capital efficiency, as the $250 million raise implies a need for immediate infusions far exceeding typical operational requirements.
The ATM’s timing—just four months after DilutionWatch began tracking DUOT—suggests a lack of preparedness for long-term cash management. The high offering ability score (100) indicates regulatory or underwriter alignment with the program, but this does not mitigate the inherent risks for shareholders.
Given DUOT’s public float of 22.6 million shares and a trading volume history (though unspecified), the ATM’s $250 million capacity could translate to rapid share issuance. If the underwriter prioritizes speed to meet DUOT’s cash needs, the program could exhaust its shelf capacity within months, particularly if the stock trades in a narrow range.
The institutional ownership percentage (50.74%) adds complexity. Large holders may resist aggressive dilution, but their influence is uncertain without transparency on voting rights or insider transactions.
DUOT’s convertible securities already pose a 220.5% dilution risk to existing shareholders, far exceeding the ATM’s 63.2% potential. With 64.65 million convertible shares outstanding, conversion could swell the share count by over double its current size, devastating equity value.
Outstanding warrants (934,581 shares, covering 3.19% of the current float) add incremental dilution risk. While modest compared to convertibles, their proximity to the money (implied by the 3.2% dilution metric) could activate if the stock rallies post-ATM.
The ATM’s $250 million capacity, if fully utilized, would add shares equivalent to 63.2% of DUOT’s market cap. Assuming proportional share issuance, this could multiply the share count by 1.6x, depending on execution prices. Combined with convertibles, total dilution potential exceeds 280%, creating a severe headwind for shareholder value retention.
As of the filing date (June 2026), there is no historical data on DUOT’s prior ATM usage due to DilutionWatch’s tracking start date (February 2026). This lack of historical context limits analysis of the company’s capital-raising patterns, though the current program’s scale suggests a departure from conservative financial management.
DilutionWatch monitors shelf registrations, ATM offerings, warrant exercises, and cash runway across thousands of public companies — updated daily from SEC filings.
Get Full Access — Free Trial →